Wasdell is to build a 70,000 sq. ft. greenfield facility on a c.2.88 hectare site at IDA’s site in Mullagharlin, Dundalk, representing an investment of €30M.
The €30m investment will see 300 jobs created over the next five years at the IDA’s site in Mullagharlin, Dundalk.
The privately owned British company’s capability includes clinical trials packing, primary and secondary packaging and distribution of biopharmaceutical products.
The company also offers contract manufacturing services with FDA and MHRA approved analytical and microbiology laboratories.
According to local deputy Peter Fitzpatrick: “Wasdell are going to make Dundalk their hub for servicing the European market post-Brexit”.
Earlier this year, the group announced their plans to build the new pharmaceutical packaging, testing and distribution facility in Ireland, close to the Dublin area.
The 70,000 sq ft site will service the pharma and healthcare industries and house 12 bespoke production suites.
Group MD Martin Teedham said that a site in Ireland will be a means to facilitate a new build in south west England “as well as an exciting opportunity for the group and specifically the Wasdell Packaging division”.
“Having a facility in Ireland and the European market makes sense and we are very excited about this new opportunity as well as extending our geographical footprint,” he said.
Roles in Wasdell’s new plant will include: general management, QA/QC including QPs, production manager and supervisors, laboratory, engineering and maintenance, production operatives, warehouse, finance and administration, health & safety and human resources.